Wuhan General Stock Price, News & Analysis
Company Description
Wuhan General (OTC Link: WUHN) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $5.5K.
WUHN stock has gained 50.0% over the past year. Shares last traded at $0.0003.
This page provides a comprehensive overview of WUHN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Wuhan General (WUHN) stock last traded at $0.0003. Over the past 12 months, the stock has gained 50.0%. At a market capitalization of $5.5K, WUHN is classified as a micro-cap stock with approximately 55.1M shares outstanding.
Latest News
Wuhan General has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. View all WUHN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Wuhan General (WUHN) currently stands at 27.0 thousand shares, representing 0.2% of the float. This relatively low short interest suggests limited bearish sentiment. The 6.0 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Wuhan General (WUHN) currently stands at 6.0 days, down 99.1% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has decreased 98% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
WUHN Company Profile & Sector Positioning
Wuhan General (WUHN) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing WUHN often look at related companies in the same sector, including CRAFT 1861 (BGPPF), Mj Holdings (MJNE), Bloomios Inc (BLMS), Wowi (WOWU), and Cen Biotech (CENBF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate WUHN's relative position within its industry.